EyePoint settles DOJ False Claims Act probe for $4.68M; enters 5-year CIA

EyePoint, Inc.

Settlement payment of $4,678,981.86 plus 4.25% interest from Jan 28, 2026, due within 14 days.
No admission of liability; DOJ releases civil claims related to DEXYCU marketing (kickbacks, sampling).
5-year Corporate Integrity Agreement with OIG-HHS requires compliance officer, board oversight, independent review.
Company also pays $166,500 in relator's attorney fees within 60 days.
DEXYCU commercialization ended in 2023; company will use cash on hand for payments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.